Arrangementer knyttet til Livsvitenskap
Kommande

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

Welcome to the second Life Science Growth House innovation hangout – a new meeting place for academia and industry. This hangout is a collaboration with the Association of the Pharmaceutical Industry in Norway (LMI). Topic: Tomorrow’s medicine – advanced therapies, cell therapy, precision medicine and nuclear medicine.

The Dynamic Kinetochore workshop has become the major venue for discussing the molecular details of kinetochore formation, structure and control and their relevance to cancer and other human diseases. The meeting encompasses the latest unpublished and cutting-edge research in the field.

Welcome to the third Life Science Growth House innovation hangout – a new meeting place for academia and industry. This hangout is a collaboration with The Life Science Cluster. Topic: Competence in and beyond academia.
Sustainable cancer care using molecular tests - from a prostate cancer perspective

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
Tidlegare
Dr. Marta Melé, group leader at the Barcelona Supercomputing Centre, Spain, will present her research on "The anatomy of expression and alternative splicing variation across human traits."

SPARK Europe Educational Forum are monthly open meetings hosted by UiO:Life Science and SPARK Europe partners.
Dr. Renée Beekman, Group Leader at the Centre for Genomic Regulation, Barcelona, Spain, will present her lecture "Understanding early lymphoma formation from a single-cell epigenomics and 3D chromatin perspective."

Welcome to the first-ever Life Science Growth House innovation hangout – a new meeting place for academia and industry. This hangout is a collaboration with Oslo Cancer Cluster. Topic: Tomorrow´s treatment – advancing innovations from academia to industry in cancer and beyond.
Dr. Bart Deplancke, Professor at the École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, will present his lecture "Resolving the molecular mechanisms underlying regulatory variation-mediated phenotypic diversity."

UiO:Life Sciences' first generation of convergence environments started up in 2017. Their research period is about to finish. Welcome to join us celebrating their achievements.

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

MSc. Frøydis Sved Skottvoll at the Department of Chemistry, Faculty of Mathematics and Natural Sciences, is defending her thesis «Liver organoids, mass spectrometry and separation science» for the degree of Philosophiae Doctor.

From the end of February, the new innovation unit at the University of Oslo – the Life Science Growth House – will be an open door for researchers and students who need help to mature ideas at an early stage; leaders and administrative employees who support the innovative researchers; and existing and new external collaborators. At this launch seminar we gather the whole innovation ecosystem in life sciences in Oslo.

Plants have been used for thousands of years in the treatment of human diseases. With over 390,000 known plant species, how do we identify which plants are potential sources for novel pharmaceuticals?
Dr. Fran Supek, Group Leader at the Institute for Research in Biomedicine, Barcelona, Spain, will present his work on "Mutation clusters in cancer genomes: causes, consequences and opportunities."

In the autumn of 2021, the method for organ donation called cDCD (controlled donation after circulatory death) was approved in Norway after a long and thorough process. In this process, critical questions were asked although the method is already established in many other countries. In order to maintain good trust in the health care system, we want to address this questions surrounding organ donation after cardiac arrest, and provide some insights into how cDCD is performed in practice: How is the dying patient and relatives taken into account? What exactly is cDCD?

This event will give a general overview of radiation therapy with focus on proton therapy and its benefits for cancer patients compared to standard treatment with high-energy X-rays. You will also have a great opportunity to get knowledge on effects of radiation therapy from clinicians, with emphasis on side effects. Finally, a survivor of head and neck cancer will share his experience.

Welcome to our digital event during Oslo Life Science Conference.

InLifeScience is the annual conference for industrial life sciences. The conference highlights the potential for life sciences in Norway, how innovation is realized from pre-commercial to upscaling. What challenges characterize the different steps - and what kind of support you can get in each step.